Diagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.

Syst Rev 2013 Jun 6;2:37. Epub 2013 Jun 6.

Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Keelung, No.222, Mai-Chin Road, Keelung 20401, Taiwan.

Background: Diagnosis of early-stage hepatocellular carcinoma (HCC) followed by curative resection or liver transplantation offers the best chance for long-term patient survival. Clinically, ultrasonography has suboptimal sensitivity for detecting early-stage HCC. Several serological tests including alpha-fetoprotein (AFP), the ratio of lens culinaris agglutinin-reactive alpha-fetoprotein to total AFP (AFP-L3/AFP), des-gamma carboxyprothrombin (DCP), and glypican-3 (GPC-3) have been widely investigated as diagnostic biomarkers for early-stage HCC in at-risk populations. However, these tests are not recommended for routine HCC screening. Our objective is to determine the diagnostic performance of AFP, AFP-L3/AFP, DCP, and GPC-3 for the detection of HCC, particularly early-stage tumors meeting the Milan criteria.

Methods/design: We will include cross-sectional studies that consecutively or randomly recruit target populations. We will search the Cochrane Library, Medline, Embase, Science Citation Index, and the Chinese National Knowledge Infrastructure. We will also search the MEDION and ARIF databases to identify diagnostic systematic reviews that include primary studies. Reference lists of relevant reviews will be searched for additional trials. Language restrictions will not be applied. Two reviewers will independently screen study eligibility and extract data. Methodological quality will be assessed according to the revised tool for the Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2). Two authors will apply the QUADAS-2 assessment to all the included studies, and any discrepancies will be resolved by the third author. The following test characteristics will be extracted into 2 × 2 tables for all included studies: true positives, false positives, true negatives, and false negatives. Study-specific estimates of sensitivity and specificity with 95% confidence intervals will be displayed in forest plots. When possible, we will use the bivariate random-effects model or the Rutter and Gatsonis hierarchical summary receiver operating characteristic model for statistical analysis. To investigate heterogeneity, we will include study designs, population characteristics, test characteristics, and types of reference standard as the study-level variables.

Discussion: Our systematic review will allow patients, clinicians, and researchers to determine the diagnostic performance of AFP, AFP-L3/AFP, DCP, and GPC-3 for the detection of early-stage HCC and the potential roles of these diagnostic biomarkers in the existing diagnostic pathways.Systematic Review Registration: PROSPERO 2013; CRD42013003879.

Download full-text PDF

http://dx.doi.org/10.1186/2046-4053-2-37DOI Listing
June 2013
5 Reads

Publication Analysis

Top Keywords

early-stage hcc
afp afp-l3/afp
diagnostic performance
will search
des-gamma carboxyprothrombin
performance afp
gpc-3 detection
systematic review
test characteristics
dcp gpc-3
afp-l3/afp dcp
agglutinin-reactive alpha-fetoprotein
included studies
diagnostic biomarkers
lens culinaris
will include
hepatocellular carcinoma
culinaris agglutinin-reactive


(Supplied by CrossRef)

HB El-Serag et al.
N Engl J Med 2011

G Fattovich et al.
Gastroenterology 2004

JM Llovet et al.
Baillieres Best Pract Res Clin Gastroenterol 2000

GN Ioannou et al.
Gastroenterology 2008

JM Llovet et al.
Hepatology 1999

JA Marrero et al.
Hepatology 2005

H Tsukuma et al.
N Engl J Med 1993

AM Di Bisceglie et al.
J Hepatol 2005

T Yamashita et al.
Cancer Res 2008

A Villanueva et al.
Annu Rev Med 2010

Similar Publications